Trials / Completed
CompletedNCT06181617
A Study to Assess Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy in Japan
Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 149 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This cross-sectional, non-interventional study will assess health-related quality of life in in patients with hypertrophic cardiomyopathy in Japan. The study consists of two phases. Phase I is a qualitative study using semi-structured in-depth interviews in participants with hypertrophic cardiomyopathy. Phase II is a quantitative study using questionnaires in participants with hypertrophic cardiomyopathy and a control group of participants who do not have hypertrophic cardiomyopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Quality of life assessment | Quality of life assessment |
Timeline
- Start date
- 2023-12-06
- Primary completion
- 2025-05-16
- Completion
- 2025-05-16
- First posted
- 2023-12-26
- Last updated
- 2025-07-22
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06181617. Inclusion in this directory is not an endorsement.